Epiville
Welcome
Module Index
Glossary
Epiville Chamber of Commerce
About this site
Requirements
Glossary
Adjusted Effect Estimates
Administrative Work (Study-Specific)
Association
Attack Rates
Blinding (referred to as "masking" in Aschengrau & Seage)
Case-Control Study
Case Definition
Case-fatality Ratio (Giesecke, pp.11-12)
Causal Heuristic
Causation
Central Limit Theorem
Cohort Study
Concordant Pairs
Confidence Interval
Confounding
Coronavirus
Correlation
Counterfactual
Cumulative Incidence
Descriptive Analysis
Detectable pre-clinical phase
Discordant Pairs
DNA adducts
Ecological Fallacy
Ecological Study
Eligibility Criteria
Elimination
Endemic
Epidemic
Equipoise
Eradication
Exchangeability
Experimental Study Design
External Validity (generalizability)
Gold standard
Group-Level Variables
Incidence proportion
Incubation period
Induction time
Informed Consent
Intent-to-Treat Analysis
Internal Validity
Isolation
Kappa statistic
Latent period
Lognormal Distribution
Loss to Follow-Up
Matching
Matched Case-Control Study
Modes of Transmission
Multivariate Analysis
Negative predictive value (predictive value negative)
Neoplastic
Non-neoplastic
Observation Bias
Observational Study Design
Outbreak
Outbreak Management
Outcome
Pandemic
Person-Time
Placebo Control
Population at Risk
Positive predictive value (predictive value positive)
PPT (Person, Place, and Time)
Prevalence
Primary prevention
Proprioception
Quarantine
Randomization
Randomized Trial
Rate Ratio
Reliability
Reproductive Rate
Restriction
Risk Difference
Risk Ratio (Relative Risk)
Secondary Attack Rate
Screening
Secondary prevention
Selection Bias
Sensitivity
Source Population
Specificity
Standardized Incidence Ratio (SIR)
Stratified Analysis
Spot Map
Surveillance
Tertiary prevention
Tumor registry
Types of epidemic
Validity
Latent period
Interval between disease onset and clinical diagnosis (Aschengrau & Seage, p. 222).
«
Previous
Next
»